BMO Capital analyst Keith Bachman raised estimates and his price target on IBM (NYSE: IBM) from $220 to $233 following Q4 results. He maintained a Market Perform rating.
Bachman said Q4 results were largely in-line but notes "with a modest negative sentiment heading into the report, we think IBM is poised for some relief, particularly given the relative underperformance of the shares in CY12."
He raised FY13 estimates from $16.82 to $16.84 and our FY14 estimates from $18.43 to $18.50.
For an analyst ratings summary and ratings history on IBM click here. For more ratings news on IBM click here.
Shares of IBM closed at $196.08 yesterday, with a 52 week range of $181.85-$211.79.